Compare Amphastar Pharmaceuticals Inc (AMPH) vs Rush Street Interactive Inc (RSI) Price & Performance

AMPH trades at $18.72, down 1.58% with bearish technical signals despite oversold RSI readings. The company reported mixed Q1 2026 results with EPS of $0.42 missing estimates of $0.70, continuing a trend of recent earnings disappointments. Valuation metrics appear reasonable with P/E of 11.29 and P/B of 1.07, while profitability remains solid with 47.34% gross margins. Recent news includes a Zacks Strong Sell rating and ongoing securities law investigation.

The stock faces near-term headwinds from earnings misses and negative analyst sentiment, though current valuations provide some downside protection. Upside potential exists if the company can execute its strategic pivot to proprietary drugs and biosimilars while managing BAQSIMI discount pressures. Key risks include ongoing legal scrutiny and competitive pressures in the generic drug market.

RSI stock trades at $33.40, up 2.36% today, with strong technical momentum and a bullish moving average signal. The company reported Q1 2026 EPS of $0.14, beating expectations, with revenue growth projected to $1.2B in 2026. Positive sentiment is driven by a 76.9% analyst buy rating and a $100M share repurchase program announced on May 5, 2026.

Outlook remains positive given earnings beats and growth initiatives, but high P/E of 98.24 signals valuation risk. Key risks include competitive pressures and reliance on sports betting trends. The consensus price target is $29.44, suggesting limited upside from current levels amid elevated expectations.